Drug Database
Back to search

United Kingdom· GB-APID-36762311000001103

Arixtra 7.5mg/0.6ml solution for injection pre-filled syringes

A fondaparinux product containing fondaparinux sodium, registered in United Kingdom by Originalis B.V.. The same ATC class is registered in 17 of our 19 countries.

ATC B01AX05

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedArixtra 7.5mg/0.6ml solution for inje…ATCB01AX05REGISTER NO.GB-APID-3676231100000…PACKS LISTED1CHECKEDSeptember 13, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about fondaparinux sodiumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Fondaparinux is registered in 17 of 19 countries.

Countries holding a registration under ATC B01AX05 (fondaparinux), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 11 of them publish a price we can compare per daily dose
Search fondaparinux products by name

Fondaparinux · ATC B01AX05

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Fondaparinux sodium
Manufacturer
Originalis B.V.
Country
United Kingdom (GB)
ATC code
B01AX05
ATC class
Fondaparinux
Defined daily dose
2.5 mg, P
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    8719923002672

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

158 interactions on record for fondaparinux.

Graded by severity as the source publishes them — 106 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check fondaparinux against other medicinesHow interaction checks work

Fondaparinux · interactions on record

158 records

  • 106 severe
  • 52 moderate

Most severe, free to view

  • DicoumarolB01AA01severe
  • WarfarinB01AA03severe
  • HeparinB01AB01severe
  • Antithrombin IIIB01AB02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Fondaparinux in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All fondaparinux products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

  • Germany · Fondaparinux-Natrium Beta
  • France · Fondaparinux Sodique Aspen
  • Ireland · Fondaparinux Sodium Aspen
  • Iceland · Arixtra
  • Liechtenstein · Arixtra
  • Norway · Arixtra

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f3b3da6e-856e-41cd-a55a-d0650bf6c02d
GET /v1/drugs/f3b3da6e-856e-41cd-a55a-d0650bf6c02d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "36762311000001103",
  "desc": "Arixtra 7.5mg/0.6ml solution for injection pre-filled syringes (Originalis B.V.)",
  "form": "Solution for injection",
  "vpid": "36060711000001100",
  "source": "dmd",
  "vtm_id": "35312611000001107",
  "strength": "12.5 mg",
  "substance": "Fondaparinux sodium",
  "ingredient": "Fondaparinux sodium",
  "supplier_code": "36751511000001108"
}
API referenceMCP serverPlans

See everything about fondaparinux.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console